Form 8-K - Current report:
SEC Accession No. 0001213900-24-012649
Filing Date
2024-02-12
Accepted
2024-02-12 16:49:23
Documents
18
Period of Report
2024-02-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193419-8k_cadrenal.htm   iXBRL 8-K 33268
2 OFFER LETTER DATED, FEBRUARY 6, 2024, BETWEEN CADRENAL THERAPEUTICS, INC. AND JE ea193419ex10-1_cadrenal.htm EX-10.1 14730
3 EMPLOYMENT AGREEMENT, EFFECTIVE AS OF FEBRUARY 8, 2024, BETWEEN CADRENAL THERAPE ea193419ex10-2_cadrenal.htm EX-10.2 159514
4 PRESS RELEASE OF CADRENAL THERAPEUTICS, INC., DATED FEBRUARY 8, 2024 ea193419ex99-1_cadrenal.htm EX-99.1 11210
5 GRAPHIC ex10-1_001.jpg GRAPHIC 3826
  Complete submission text file 0001213900-24-012649.txt   451396

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cvkd-20240206.xsd EX-101.SCH 3015
7 XBRL LABEL FILE cvkd-20240206_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE cvkd-20240206_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT ea193419-8k_cadrenal_htm.xml XML 3727
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41596 | Film No.: 24620823
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)